For healthcare professionals who also invest, this is a dual opportunity enhancing patient care while benefitting from the financial upside of this healthcare revolution Investing in the GLP-1 Revolution: Exclusive Webinar The GLP-1 revolution is creating a wave of new investment opportunities beyond just medications and we invite you to explore them with us
10.1186/s12933-017-0512-z 151
Reduz a produo de glucagon , um hormnio que eleva os nveis de glicose no sangue
Rather than the active compound being a peptide, it is instead a "small molecule", meaning it can withstand the harsh environment of the digestive system and is much cheaper to make and store
If I were a patient, and I had a choice of getting Wegovy versus a compounded version, of course I would get Wegovyif the price were the same, she says
Sources: Allie Seminer, MSc